| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | M. Eric Gershwin | Q73297886 |
| Zhe-Xiong Lian | Q61090146 | ||
| P2093 | author name string | Christopher Chang | |
| Hong-Di Ma | |||
| Yin-Hu Wang | |||
| P2860 | cites work | Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 |
| Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 | Q35062213 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 183-191 | |
| P577 | publication date | 2014-10-12 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | The intestinal microbiota and microenvironment in liver | |
| P478 | volume | 14 |
| Q38747656 | Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. |
| Q30248983 | Autoimmunity in 2015. |
| Q36770339 | Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. |
| Q35790974 | Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis |
| Q50099829 | Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure |
| Q52885250 | Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis. |
| Q37390449 | Fish gut-liver immunity during homeostasis or inflammation revealed by integrative transcriptome and proteome studies |
| Q39168770 | Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism |
| Q38723925 | Functional Immune Anatomy of the Liver-As an Allograft |
| Q35745517 | Gut microbiota modulate the immune effect against hepatitis B virus infection |
| Q57814337 | Gut microbiota translocation promotes autoimmune cholangitis |
| Q39146308 | Microbiome, autoimmunity, allergy, and helminth infection: The importance of the pregnancy period |
| Q38898139 | On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota |
| Q26768500 | Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease |
| Q26801649 | Role of gut microbiota in the modulation of atherosclerosis-associated immune response |
| Q98224235 | The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases |
| Q34474989 | The dormant blood microbiome in chronic, inflammatory diseases |
| Q26772312 | Xenobiotics and loss of tolerance in primary biliary cholangitis |
| Q90394256 | tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors |
Search more.